Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
-activated cell sorting (FACS), and immunoprecipitation (IP). Maintains and differentiates human induced pluripotent stem cells (iPSCs) into specific cell lineages using established protocols and assist with
-
, including single-cell genomics (Wright, Lloyd), sexual selection and reproduction (Wright, Pomiankowski, Hemmings, Wigby), gene editing (Dasmahapatra), experimental approaches (Wigby), and stalk-eyed fly
-
leukemia in children. We have several projects related to these general topics. Each focuses on gene regulation â“ and changes that occur in gene regulation â“ during stem cell development and
-
/mps/people/all-academic-staff/alexander-fletcher https://strawbridgelab.com/ Institutional entry requirements for PhD: For entry into this PhD programme you should hold, or expect to hold, an honours
-
; stem cells; and surgery. A number of pivotal discoveries have been made in Nottingham with current research continuing to provide exciting data, improving our understanding of breast cancer and
-
ICETA - Instituto de Ciências, Tecnologias e Agroambiente da Universidade do Porto | Portugal | 2 months ago
biomaterials, assessing the functional activity of mesenchymal stem cells in contact with innovative biomaterials; Participation in conducting and monitoring in vivo studies involving animal models of different
-
Association. Whom would we like to hire? Professional experience Must Have You hold a PhD in a relevant field (computational biology, genomics, stem cell biology, hematology etc.), or, alternatively, you hold a
-
related to these general topics. Each focuses on gene regulation – and changes that occur in gene regulation – during stem cell development and differentiation. We use mice to model pediatric malignancies
-
experience in mammalian cell culture, organoid culture and analysis, and stem cell biology. Strong skills in molecular biology, next-generation sequencing, bioinformatics, general microscopy and confocal
-
contribute directly to this effort by developing patient-specific induced pluripotent stem cell (iPSC)-derived vascular tissues to assess disease severity, drug efficacy and the potential of gene-correction